top of page
Directly Compressible (DC) Granules
YSK Labs manufactures Directly Compressible (DC) Granules — semi-formulated APIs engineered to compress into finished tablets in a single step, eliminating the need for granulation and drying. Built on our proprietary, solvent-free technology, our granules deliver higher active-ingredient content, lower excipient loads, and smaller, easier-to-swallow tablets. Available in Immediate Release (IR) and Sustained/Extended Release (SR/XR), with an annual capacity of 400–500 metric tons.
Key benefits
.png)
Single-Step Compression
no granulation, no drying
.png)
Higher Active Content
lower excipient load
.png)
Smaller Tablets
better patient swallowability
.png)
IR & SR/XR
full release-profile range
Generic Name | Release | Strength / API % | Compliance | Dossier |
|---|---|---|---|---|
ANTI-DIABETIC | ||||
Metformin HCL Granules | SR | 75%, 80% | USP | On request |
Metformin HCL Granules | IR | 86.66%, 93%, 95% | USP | On request |
Gliclazide Granules | IR | 54.05% | IH | On request |
Empagliflozin Granules | IR | 8.33% | IH | On request |
CARDIAC | ||||
Amlodipine Granules | IR | 4.17% | USP | On request |
Clopidogrel Granules | IR | 60% | USP | On request |
Flecainide Granules | IR | 40% | IH | On request |
Lisinopril Granules | IR | 5.45% | USP | On request |
Telmisartan Granules | IR | 16%, 28.88% | USP | On request |
ANTIBIOTIC | ||||
Ciprofloxacin Granules | IR | 88.45% | USP | On request |
ANTI-INFLAMMATORY / ANALGESIC | ||||
Paracetamol Granules | IR | 95.00% | USP | On request |
RESPIRATORY / ALLERGY | ||||
Fexofenadine Granules | IR | 48.36% | USP | On request |
Montelukast Granules | IR | 5.20% | IH | On request |
bottom of page